IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65
暂无分享,去创建一个
S. Kesari | Saumitra Das | K. Somasundaram | V. Santosh | S. Bhargava | Anuj Kumar | A. Arivazhagan | A. S. Hegde | V. Patil | A. Visvanathan
[1] Kulandaivelu Mahalingam,et al. Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma , 2016, Oncotarget.
[2] T. Cooper,et al. Roles for RNA-binding proteins in development and disease , 2016, Brain Research.
[3] Jun Ma,et al. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor. , 2016, Oncology reports.
[4] Sol Katzman,et al. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. , 2016, The Journal of clinical investigation.
[5] H. Goel,et al. IMP3 promotes stem-like properties in triple-negative breast cancer by regulating SLUG , 2016, Oncogene.
[6] E. Schwarz,et al. Increased insulin mRNA binding protein-3 expression correlates with vascular enhancement of renal cell carcinoma by intravenous contrast-CT and is associated with bone metastasis , 2015, Journal of bone oncology.
[7] S. Kesari,et al. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres , 2015, Journal of Translational Medicine.
[8] Jian Zheng,et al. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186 , 2015, Oncotarget.
[9] N. Chow,et al. Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer , 2015, British Journal of Cancer.
[10] Ming Zhou,et al. Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression , 2015, PloS one.
[11] N. Agarwal,et al. Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma , 2015, Journal of oncology.
[12] S. Gerstberger,et al. A census of human RNA-binding proteins , 2014, Nature Reviews Genetics.
[13] K. Taniuchi,et al. IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer , 2014, Oncotarget.
[14] B. Kazeminezhad,et al. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases. , 2014, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[15] Y. Zhang,et al. Role of IGF2BP3 in trophoblast cell invasion and migration , 2014, Cell Death and Disease.
[16] Hui Zhou,et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..
[17] D. Friedmann-Morvinski. Glioblastoma heterogeneity and cancer cell plasticity. , 2014, Critical reviews in oncogenesis.
[18] K. Somasundaram,et al. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus. , 2013, Cancer research.
[19] M. Gujrati,et al. Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma , 2013, Oncogene.
[20] C. Ménard,et al. Glioblastoma management in the temozolomide era: have we improved outcome? , 2013, Journal of Neuro-Oncology.
[21] O. Myklebost,et al. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome. , 2013, Experimental cell research.
[22] L. Pfeffer,et al. Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor κB Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch Pathway* , 2013, The Journal of Biological Chemistry.
[23] S. Dooley,et al. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells. , 2013, The Journal of clinical investigation.
[24] G. Stark,et al. PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65 , 2013, Nature Communications.
[25] Simon Kasif,et al. An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. , 2013, Cell reports.
[26] Angélica Figueroa,et al. Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition , 2013, Cellular and Molecular Life Sciences.
[27] Jun Wang,et al. Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis , 2013, International journal of molecular sciences.
[28] Raymond Moran,et al. PhysBinder: improving the prediction of transcription factor binding sites by flexible inclusion of biophysical properties , 2013, Nucleic Acids Res..
[29] A. Mercurio,et al. IMP3 Protein Promotes Chemoresistance in Breast Cancer Cells by Regulating Breast Cancer Resistance Protein (ABCG2) Expression* , 2013, The Journal of Biological Chemistry.
[30] G. Pelicci,et al. Cancer stem cell contribution to glioblastoma invasiveness , 2013, Stem Cell Research & Therapy.
[31] N. Onishi,et al. Up-Regulation of Imp3 Confers In Vivo Tumorigenicity on Murine Osteosarcoma Cells , 2012, PLoS ONE.
[32] Saumitra Das,et al. Targeting Ribosome assembly on the HCV RNA using a small RNA molecule , 2012, RNA biology.
[33] Norman E. Davey,et al. Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins , 2012, Cell.
[34] Hui Liu,et al. AnimalTFDB: a comprehensive animal transcription factor database , 2011, Nucleic Acids Res..
[35] Tzong-Shiue Yu,et al. A restricted cell population propagates glioblastoma growth after chemotherapy , 2012 .
[36] G. Brewer,et al. RNA-binding Protein Insulin-like Growth Factor mRNA-binding Protein 3 (IMP-3) Promotes Cell Survival via Insulin-like Growth Factor II Signaling after Ionizing Radiation* , 2011, The Journal of Biological Chemistry.
[37] G. Mor,et al. Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway , 2011, Cell cycle.
[38] K. Thennarasu,et al. Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2* , 2011, The Journal of Biological Chemistry.
[39] Nathan D Price,et al. A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations , 2011, Proceedings of the National Academy of Sciences.
[40] S. Senju,et al. Peptides derived from human insulin‐like growth factor‐II mRNA binding protein 3 can induce human leukocyte antigen‐A2‐restricted cytotoxic T lymphocytes reactive to cancer cells , 2011, Cancer science.
[41] J. Mosser,et al. DNA methylation in glioblastoma: impact on gene expression and clinical outcome , 2010, BMC Genomics.
[42] Antony Hsieh,et al. IGFBP2 promotes glioma tumor stem cell expansion and survival. , 2010, Biochemical and biophysical research communications.
[43] Scott B. Dewell,et al. Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP , 2010, Cell.
[44] Roger E. McLendon,et al. Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth , 2010, PLoS biology.
[45] S. Almo,et al. ZBP1 recognition of beta-actin zipcode induces RNA looping. , 2010, Genes & development.
[46] R. McLendon,et al. Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth , 2009, Stem cells.
[47] D. Huntsman,et al. IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype , 2009, Modern Pathology.
[48] Hui Wang,et al. c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells , 2008, PloS one.
[49] T. Glisovic,et al. RNA‐binding proteins and post‐transcriptional gene regulation , 2008, FEBS letters.
[50] R. Britto,et al. Novel Glioblastoma Markers with Diagnostic and Prognostic Value Identified through Transcriptome Analysis , 2008, Clinical Cancer Research.
[51] Yusuke Nakamura,et al. Identification of human leukocyte antigen‐A24‐restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy , 2007, Cancer science.
[52] Alexander Brawanski,et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. , 2007, Cancer research.
[53] T. Gilmore,et al. Inhibitors of NF-kappaB signaling: 785 and counting. , 2006, Oncogene.
[54] A. Baldwin,et al. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. , 2006, Oncogene.
[55] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[56] Xavier Matias-Guiu,et al. NF-kB in development and progression of human cancer , 2005, Virchows Archiv.
[57] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[58] P. Barker,et al. TRAF6‐dependent NF‐kB transcriptional activity during mouse development , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.
[59] Jan Christiansen,et al. Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability. , 2004, Nucleic acids research.
[60] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[61] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[62] A. Aggarwal,et al. Structure of NF-kappaB p50/p65 heterodimer bound to the PRDII DNA element from the interferon-beta promoter. , 2002, Structure.